We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New Drug Information.
- Abstract
The article reports on the drug Embeda, an opioid and opioid antagonist for moderate to severe pain management manufactured by King Pharmaceuticals. Embeda contains pellets of an extended-release formulation of morphine and naltrexone. The article discusses the efficacy of Embeda in clinical trials, contraindications, interactions, and adverse reactions, and precautions for those taking the drug. Facts about chronic pain are included.
- Subjects
ANALGESICS; OPIOIDS; KING Pharmaceuticals Inc.; DRUG efficacy; DRUG side effects; DRUG interactions
- Publication
JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2009, Vol 22, Issue 11, p12
- ISSN
1547-1896
- Publication type
Article
- DOI
10.1097/01720610-200911000-00007